[Assessment of annual health insurance reimbursement for oncology drugs in Hungary].
Boncz I, Donkáné Verebes E, Oberfrank F, Kásler M.
Boncz I, et al.
Magy Onkol. 2010 Dec;54(4):283-8. doi: 10.1556/MOnkol.54.2010.4.2.
Magy Onkol. 2010.
PMID: 21163758
Free article.
Hungarian.
The reimbursement of oncological drugs represents a significant expenditure for the Hungarian National Health Insurance Fund Administration (OEP). Boncz I, Donka-Verebes E, Oberfrank F, Kasler M. Assessment of annual health insurance reimbursement of oncology drugs …
The reimbursement of oncological drugs represents a significant expenditure for the Hungarian National Health Insurance Fund Administration …